QMS Medical Allied Services
QMSMEDI NSE
QMS Medical Allied Services
HealthcareNSE: QMSMEDI Medical Equipment
Key Fundamentals
MicrocapMedical EquipmentHealthcareMarket Cap
₹291 Cr
Volatility
Moderate
P/E Ratio
28.41
EBITDA
₹25.88 Cr
Return on Equity
12.79%
Debt to Equity
0.65
Book Value
₹53.88
52W High
₹165
52W Low
₹68.95
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
3- Stock is trading at 2.93 times its book value
- Company has a low return on equity of 12.0% over last 3 years.
- Promoter holding has decreased over last 3 years: -5.56%
Growth Rate
Revenue Growth
9.63% lower than
3Y
Net Income Growth
-14.16% lower than
3Y
Cash Flow Change
—
ROE
11.51% lower than
3Y
ROCE
5.77% level than
3Y
EBITDA Margin (Avg.)
-13.49% lower than
3Y
Quarterly Results
| Particulars | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 35.24 | 32.29 | 37.2 | 43.87 | 44.58 | 46.5 | 44.7 | 37.26 | 44.42 | 56.87 |
| Expenses | 30.4 | 28.34 | 29.96 | 36.93 | 38.21 | 39.96 | 37.78 | 30.51 | 38.5 | 48.56 |
| Operating Profit | 4.84 | 3.95 | 7.24 | 6.94 | 6.37 | 6.54 | 6.92 | 6.75 | 5.92 | 8.31 |
| OPM % | 13.73% | 12.23% | 19.46% | 15.82% | 14.29% | 14.06% | 15.48% | 18.12% | 13.33% | 14.61% |
| Other Income | 0.15 | 0.11 | 0.33 | 0.19 | 1.09 | 0.32 | 0.22 | 0.3 | 0.22 | 0.42 |
| Interest | 0.81 | 0.99 | 1.07 | 1.31 | 1.41 | 1.44 | 1.36 | 1.75 | 2.08 | 1.71 |
| Depreciation | 0.88 | 0.88 | 0.84 | 0.86 | 1.36 | 0.93 | 0.94 | 1.02 | 1.39 | 1.47 |
| PBT | 3.3 | 2.19 | 5.66 | 4.96 | 4.69 | 4.49 | 4.84 | 4.28 | 2.67 | 5.55 |
| Tax % | 25.76% | 29.68% | 25.27% | 30.24% | 23.24% | 29.62% | 26.24% | 25.7% | 29.21% | 28.65% |
| Net Profit | 2.44 | 1.54 | 4.23 | 3.47 | 3.6 | 3.16 | 3.58 | 3.17 | 1.88 | 3.96 |
| EPS in Rs | 1.26 | 0.8 | 1.78 | 1.51 | 1.73 | 1.52 | 1.61 | 1.24 | 0.82 | 1.89 |
Profit & Loss
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| Sales | 122 | 156 | 173 | 183 |
| Expenses | 104 | 130 | 146 | 155 |
| Operating Profit | 18 | 25 | 27 | 28 |
| OPM % | 15% | 16% | 15% | 15% |
| Other Income | 0 | 2 | 1 | 1 |
| Interest | 3 | 5 | 7 | 7 |
| Depreciation | 3 | 4 | 5 | 5 |
| PBT | 12 | 19 | 16 | 17 |
| Tax % | 26% | 27% | 28% | — |
| Net Profit | 9 | 14 | 12 | 13 |
| EPS in Rs | 4.66 | 6.26 | 5.21 | 5.56 |
| Div. Payout % | 0% | 0% | 10% | — |
Balance Sheet
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity Capital | 18 | 18 | 19 |
| Reserves | 61 | 72 | 85 |
| Borrowings | 35 | 60 | 68 |
| Other Liabilities | 22 | 40 | 41 |
| Total Liabilities | 135 | 190 | 213 |
| Fixed Assets | 24 | 53 | 57 |
| CWIP | 2 | 3 | 0 |
| Investments | 2 | 3 | 5 |
| Other Assets | 108 | 131 | 150 |
| Total Assets | 135 | 190 | 213 |
Cash Flow
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Operating | 1 | 20 | 19 |
| Investing | -3 | -45 | -20 |
| Financing | 0 | 26 | 1 |
| Net Cash Flow | -1 | 1 | 0 |
| Free Cash Flow | 1 | 20 | 19 |
| CFO/OP | 26 | 101 | 91 |
Ratios
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Debtor Days | 124 | 101 | 142 |
| Inventory Days | 172 | 176 | 181 |
| Days Payable | 90 | 76 | 73 |
| Cash Conversion Cycle | 205 | 202 | 250 |
| Working Capital Days | 148 | 100 | 105 |
| ROCE % | — | 17% | 13% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view QMS Medical Allied Services insights
52 extracted metrics + investor summaries across FY21–FY26.
Documents
1
Analysts/Institutional Investor Meet/Con. Call Updates
10 June 2026 - FY26 earnings call transcript: revenue INR172.9 crore, PAT INR11.9 crore, services growth guidance reiterated. 10 June 2026 - FY26 earnings call transcript: revenue INR172.9 crore, PAT INR11.9 crore, services growth guidance reiterated.
2
Disclosure under SEBI Takeover Regulations
5 June 2026 - Company filed promoters’ Regulation 31(4) disclosure under SEBI takeover regulations. 5 June 2026 - Company filed promoters’ Regulation 31(4) disclosure under SEBI takeover regulations.
3
Analysts/Institutional Investor Meet/Con. Call Updates
4 June 2026 - QMS Medical released Q4/FY26 investor presentation; FY26 revenue rose 11% to ₹172.9 crore, PAT fell 13% to ₹11.9 crore. 4 June 2026 - QMS Medical released Q4/FY26 investor presentation; FY26 revenue rose 11% to ₹172.9 crore, PAT fell 13% to ₹11.9 crore.
4
General Updates
4 June 2026 - Board approved FY26 audited results, Rs0.50 dividend, internal auditor reappointment, and NSE Emerge migration IM. 4 June 2026 - Board approved FY26 audited results, Rs0.50 dividend, internal auditor reappointment, and NSE Emerge migration IM.
5
Analysts/Institutional Investor Meet/Con. Call Updates
4 June 2026 - Audio recording uploaded for FY26 audited results earnings call held June 4, 2026. 4 June 2026 - Audio recording uploaded for FY26 audited results earnings call held June 4, 2026.
Frequently Asked Questions about QMS Medical Allied Services
What does QMS Medical Allied Services Ltd do?
Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]
Where is QMS Medical Allied Services Ltd (QMSMEDI) listed?
QMS Medical Allied Services Ltd trades as QMSMEDI on the NSE.
Which sector does QMS Medical Allied Services Ltd belong to?
QMS Medical Allied Services Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the market capitalisation of QMS Medical Allied Services Ltd?
QMS Medical Allied Services Ltd has a market capitalisation of ₹290.84 Cr, which places it in the Small Cap band.
What is the PE ratio of QMS Medical Allied Services Ltd?
QMS Medical Allied Services Ltd trades at a PE ratio of 28.41, against a book value of ₹53.88 per share.
What is the 52-week high and low of QMS Medical Allied Services Ltd?
Over the last 52 weeks QMS Medical Allied Services Ltd has traded between ₹68.95 and ₹165.
Does QMS Medical Allied Services Ltd pay dividends?
QMS Medical Allied Services Ltd has a dividend yield of 0.33%.
What is the Return on Equity (ROE) of QMS Medical Allied Services Ltd?
QMS Medical Allied Services Ltd reported a return on equity of 12.79%. Its debt-to-equity ratio is 0.65.
Company Information
Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/QMSMEDI.md for QMS Medical Allied Services Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.